Inventor · disambiguated record
Zhaoguo Chen
Also filed as: CHEN ZHAOGUO
8 granted patents·8 pending applications·10 citations·filing 2015–2022
77Inventor score
Files withMEDSHINE DISCOVERY INC11CHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LTD1CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD1GUIZHOU INOCHINI TECH CO LTD1SOTER BIOPHARMA PTE LTD1
Top patents by PatentIndex Score
16 records- 0184US11433053B2LSD1 inhibitor and preparation method and application thereofCSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2018·Granted Sep 6, 2022·3 cites·30 claims
- 0278US11117899B2[1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitorMEDSHINE DISCOVERY INC·Filed 2018·Granted Sep 14, 2021·3 cites·23 claims
- 0377US9856264B2Isoquinolinesulfonyl derivative as RHO kinase inhibitorMEDSHINE DISCOVERY INC·Filed 2015·Granted Jan 2, 2018·3 cites·19 claims
- 0474US11377444B2Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitorsMEDSHINE DISCOVERY INC·Filed 2018·Granted Jul 5, 2022·1 cites·20 claims
- 0556US2024158413A1Fused polycyclic substituted 5-carboxylic acid thienopyrimidine dione compound and use thereofSOTER BIOPHARMA PTE LTD·Filed 2022·Application pending·0 cites
- 0653US11649239B2Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)methanol (compound 1)MEDSHINE DISCOVERY INC·Filed 2019·Granted May 16, 2023·0 cites·12 claims
- 0752US2023365558A1Tetrahydroisoquinoline derivative and use thereofMEDSHINE DISCOVERY INC·Filed 2021·Application pending·0 cites
- 0850US2024254145A1Salt form and crystal form of heterocyclic substituted purinone derivativeZAI LAB SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 0950US2022267310A1Quinazoline and cinnoline derivatives as dna-pk inhibitorMEDSHINE DISCOVERY INC·Filed 2020·Application pending·0 cites
- 1049US2023055321A1Pyrimidopyrrole spiro compounds and derivatives thereof as dna-pk inhibitorsMEDSHINE DISCOVERY INC·Filed 2020·Application pending·0 cites
- 1148US2023026616A1Pyrimidoimidazole compounds used as dna-pk inhibitorsMEDSHINE DISCOVERY INC·Filed 2020·Application pending·0 cites
- 1246US2022306622A1Salt and crystal form of mtorc1/2 dual kinase activity inhibitor and preparation method thereforMEDSHINE DISCOVERY INC·Filed 2020·Application pending·0 cites
- 1345US11155559B2Sulfonyl-substituted isoquinolines as inhibitors of RHO kinase and hERG potassium channel activityCHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LTD·Filed 2018·Granted Oct 26, 2021·0 cites·11 claims
- 1442US12030897B2Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and application thereofMEDSHINE DISCOVERY INC·Filed 2019·Granted Jul 9, 2024·0 cites·14 claims
- 1540US2021078958A1Quinazoline derivative and use thereofMEDSHINE DISCOVERY INC·Filed 2018·Application pending·0 cites
- 1636US11046720B2Dimethylphosphine oxide compoundGUIZHOU INOCHINI TECH CO LTD·Filed 2019·Granted Jun 29, 2021·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Zhaoguo Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →